inhibition egf receptor binding mig6 activating kinase domain interface 
members epidermal growth factor receptor family egfr/erbb1 erbb2/her2 erbb3/her3 erbb4/her4 key targets inhibition cancer therapy critical activation formation asymmetric dimer intracellular kinase domains carboxy-terminal lobe c lobe one kinase domain induces active conformation cytoplasmic protein mig6 mitogen-induced gene also known errfi1 interacts inhibits kinase domains egfr erbb2 refs crystal structures complexes egfr kinase domain fragment mig6 show similar residue epitope segment mig6 binds distal surface clobe kinase domain biochemical cell-based analyses confirm interaction contributes egfr inhibition blocking formation activating dimer interface longer mig6 peptide extended c terminal segment increased potency inhibitor activated egfr kinase domain retaining critical dependence segment show signalling egfr molecules contain constitutively active kinase domains still requires formation asymmetric dimer underscoring importance dimer interface blockage mig6-mediated inhibition 
